Borowicz D, Skrobała A, Kruszyna-Mochalska M, Malicki J. Does CyberKnife improve dose distribution versus IMRT and VMAT on a linear accelerator in low-risk prostate cancer? CyberKnife, IMRT and VMAT in low risk prostate cancer. Radiol Oncol [Internet]. 2022 Jul. 3 [cited 2026 Jun. 12];56(2):259-66. Available from: https://www.radioloncol.com/index.php/ro/article/view/3786